Curie Brief
Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
News
Some genetic variants linked to lupus may actually supercharge the immune system's ability to fight viruses, according to a new study in The American Journal of Human Genetics. Researchers found that a lupus-associated haplotype near the IRF7 gene ramps up interferon-alpha production — a key antiviral weapon. The catch? That same heightened immune response may tip the scales toward autoimmunity.
A new study published in The American Journal of Human Genetics offers a compelling explanation for why genetic variants tied to lupus remain surprisingly common: they may give the immune system a leg up against viral infections. Researchers at Cincinnati Children's Hospital Medical Center focused on a lupus-associated genetic haplotype linked to IRF7, a transcription factor that drives the production of type I interferons — the body's frontline antiviral molecules.
The team found that individuals carrying this haplotype mount a stronger interferon-alpha (IFN-α) response when challenged by viral signals. That's a double-edged sword: better antiviral defense on one hand, but a higher risk of the chronic, excessive immune activation that defines lupus on the other. This evolutionary tradeoff — where a protective immune advantage comes bundled with autoimmune risk — reframes how we think about lupus-linked variants. They're not simply "broken" genes; they're a different immune operating mode.
Key Takeaways:
Why it matters: Understanding why lupus risk variants persist — and what they actually do in immune cells — moves science closer to precision therapies that can dial down autoimmunity without dismantling the body's viral defenses.
